![](https://investorshub.advfn.com/uicon/48355.png?cb=1551739062)
Tuesday, February 23, 2021 11:41:00 AM
"The company has very encouraging in vivo and in vitro preclinical data, a demonstrated molecular mechanism of action and a robust scientific rational for the continued commercial development of RPI-78M," reported Dale VanderPutten, PhD, Chief Scientific Officer of Nutra Pharma. "In preparing for the planned testing and proposed clinical trials for the drug, we are improving and updating our production suite and laboratories," he continued. "We are working with our consultants and outside experts to improve our Quality Control and Quality Assurance procedures. We are also making investments in the necessary equipment for environmental monitoring, standards testing and drug validation that will be necessary as we move all of these projects forward over the coming months," Dr. VanderPutten concluded.
As Nutra Pharma moves forward with these projects, they will provide further updates throughout the rest of 2021.
About Nutra Pharma Corp.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin®, Equine Pain-Away and Pet Pain-Away. For additional information about Nutra Pharma, visit:
http://www.NutraPharma.com or
http://www.nyloxin.com
http://www.petpainaway.com
http://www.equinepainaway.com
SEC Disclaimer
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The facility improvements should not be construed as an indication in any way whatsoever of the future value of the Company's common stock or its financial value. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
Contact:
Nutra Pharma Corp.
Nina Goldstein
877-895-5647
IR@nutrapharma.com
Latest NPHC Messages
Carjockey2 Tue Feb 23, 2021 11:25 AM (13 minutes ago)
Agreed..
![smile](/images/emoticon01.gif)
crudeoil24 Tue Feb 23, 2021 11:25 AM (14 minutes ago)
NPHC & SNSS are nice upside movers!
RSI38 Tue Feb 23, 2021 11:11 AM (27 minutes ago)
Me too... It's always good to add cheapies
Toggrok124 Tue Feb 23, 2021 11:03 AM (35 minutes ago)
Most non reporting OTC tickers Fidelity won't let
KnapperAnticipator Tue Feb 23, 2021 11:03 AM (35 minutes ago)
Bigly
otcbbnpink Tue Feb 23, 2021 11:03 AM (35 minutes ago)
SO GLAD I ADDED WHEN IT HIT $0.0065
winvester7189 Tue Feb 23, 2021 11:00 AM (39 minutes ago)
On Twitter some people have said Fidelity won't
Carjockey2 Tue Feb 23, 2021 10:54 AM (44 minutes ago)
Agreed!!!!!
cngreen Tue Feb 23, 2021 10:53 AM (45 minutes ago)
1. Nutra Pharma owns over 20 patents and
otcbbnpink Tue Feb 23, 2021 10:44 AM (54 minutes ago)
WOW - - all I see is red
See More Posts on NPHC Message Board
Nutra Pharma (PK) (USOTC:NPHC)
Intraday Stock Chart
Tuesday 23 February 2021 Click Here for more Nutra Pharma (PK) Charts.
New York Yankees and Duke Basketball
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM